Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by SPHK1 catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), a lipid mediator with both intra- and extracellular functions. Additionally we are shipping Sphingosine Kinase 1 Antibodies (200) and Sphingosine Kinase 1 Proteins (13) and many more products for this protein.
Showing 3 out of 8 products:
Sk1 and Sk2 (show KCNN2 ELISA Kits) are not redundant in biological function and are essential for diverse physiological functions in Drosophila
SPHK/phyto-S1P (show MBTPS1 ELISA Kits) and PLDalpha1A are co-dependent in amplification of response to ABA, mediating stomatal closure in Arabidopsis.
Sphingosine kinase 1 phosphorylates sphingosine-1-phosphate and phytosphingosine-1-phosphate, and is coordinately regulated with sphingosine-1-phosphate phosphatase.
Melatonin administration significantly inhibited those changes and induced a decreased immunoreactivity for rabbit hemorrhagic disease virus VP60 antigen in the liver. Results obtained indicate that the SphK1/S1P (show MBTPS1 ELISA Kits) system activates in parallel to viral replication and the inflammatory process induced by the virus.
demonstrated the roles played by miR (show MLXIP ELISA Kits)-144-3p and FN1 (show FN1 ELISA Kits) in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC (show F9 ELISA Kits)
SphK1 is associated with the proliferation and invasiveness of CRC (show CALR ELISA Kits) cells and the SphK1 gene may contribute to a novel therapeutic approach against CRC (show CALR ELISA Kits).
The levels of SphK1 were significantly increased in triple-negative breast cancer patients compared with normal controls. SphK1 knockdown with siRNA decreased TNBC cell proliferation and inhibited cell migration/invasion, suggesting that SphK1 has an important role in TNBC.
SPHK1 mRNA is up-regulation in colorectal cancer.
Found that upregulation of SphK1 expression in the stiff substrate is dominant in metastatic cancer cells but not in primary cancer cells. These results suggest that alterations in the mechanical environment of the extracellular matrix surrounding the tumor cells actively regulate cellular properties such as secretion, which in turn, may contribute to cancer progression.
In conclusion, these data suggested that HuR (show ELAVL1 ELISA Kits) bound to SphK1 mRNA and played a crucial role in TGF-beta1 (show TGFB1 ELISA Kits)-induced hepatic stellate cell activation.
low oxLDL concentration triggers sprouting angiogenesis that involves ROS (show ROS1 ELISA Kits)-induced activation of the neutral sphingomyelinase-2/sphingosine kinase-1 pathway, and is effectively inhibited by GW4869.
SphK1 expression is functionally associated to cellular proliferation, apoptosis, invasion and mitotane sensitivity of adrenocortical carcinoma.
Data show that long non-coding RNA HULC promotes tumor angiogenesis in liver cancer through microRNA miR (show MLXIP ELISA Kits)-107/E2F1 transcription factor (E2F1 (show E2F1 ELISA Kits))/sphingosine kinase 1 (SPHK1) signaling.
High SPHK1 expression is associated with ovarian cancer.
These findings suggest that the inhibitory effect of these plant extracts on the activation of AGEs/RAGE (show AGER ELISA Kits)/SphK1 signaling pathway in db/db (show LEPR ELISA Kits) diabetic mice kidney is a novel mechanism by which they exert renoprotective effects in diabetic nephropathy.
Keratinocyte-specific deletion of Traf2 (show TRAF2 ELISA Kits), but not Sphk1 deficiency, disrupted TNF (show TNF ELISA Kits) mediated NF-kappaB (show NFKB1 ELISA Kits) and MAP kinase (show MAPK1 ELISA Kits) signalling and caused epidermal hyperplasia and psoriatic skin inflammation.
SphK1 dependent PKC-delta (show PKCd ELISA Kits) activation plays an important role in promoting NF-kappaB (show NFKB1 ELISA Kits) activation and inflammatory response in acute liver failure, and inhibition of PKC-delta (show PKCd ELISA Kits) activation might be a potential therapeutic strategy for this disease.
Inhibition of SphK1 ameliorates drug-induced acute liver failure by reducing HMGB1 (show HMGB1 ELISA Kits) cytoplasmic translocation in liver cells.
Collectively, our results demonstrate that PF-543 exerts potent anti-CRC (show SCRIB ELISA Kits) activity in vitro and in vivo.
transient receptor potential channel 1 suppression of basal sphingosine kinase 1 activity enables endothelial cell-barrier destabilization by edemagenic agonists
Based on these findings, the authors propose new roles for SK1 in affecting innate responses that regulate susceptibility to dengue virus infection.
Together, these results suggest that alpha-MSH alleviates Dex-induced damages to cultured osteoblasts through activating MC4R (show MC4R ELISA Kits)-SphK1 signaling.
The study demonstrates a new pathway connecting SphK1 and PPARgamma (show PPARG ELISA Kits) involved in the pathogenesis of hepatocellular steatosis.
Inhibition of SK1 attenuates the second phase of transmembrane Calcium influx.
The protein encoded by this gene catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), a lipid mediator with both intra- and extracellular functions. Intracellularly, S1P regulates proliferation and survival, and extracellularly, it is a ligand for cell surface G protein-coupled receptors. This protein, and its product S1P, play a key role in TNF-alpha signaling and the NF-kappa-B activation pathway important in inflammatory, antiapoptotic, and immune processes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
, sphingosine kinase 1
, sphingosine kinase I
, SK 1
, SPK 1